Approval · Notice of Compliance 952 · 2000
ONE-ALPHA: Notice of Compliance 952
Issued July 21, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 952
- Date
- July 21, 2000
- Company
- Leo Laboratories Canada Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: secondary hyperparathyroidism
- Therapeutic class
- Vitamin d analogue
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONE-ALPHA | 02242502 | Marketed |
Medicinal ingredients
- ALFACALCIDOL 2 MCG per ML